FMED

Fidelity Disruptive Medicine ETF

$27.19

+0.00%

Market closed. Last update: 11:59 AM ET

📎 Investment Objective

The Fidelity Disruptive Medicine ETF seeks to provide investment results that correspond, before fees and expenses, to the performance of the Fidelity Disruptive Medicine Index, which is designed to reflect the performance of companies engaged in the development and production of innovative medical technologies and treatments.

Overview

ETF tracking Fidelity Disruptive Medicine ETF

Category Innovation

Issuer Other

Inception Date 2023-06-12

Market Cap $59.8M

Average Volume N/A

Dividend Yield 0.41%

52-Week Range $21.43 - $27.32

VWAP $27.26

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

🎯 Investment Strategy

The ETF invests in a diversified portfolio of companies that are at the forefront of developing and commercializing innovative medical products, services, and technologies. This includes companies involved in areas such as gene therapy, regenerative medicine, digital health, and other disruptive healthcare innovations.

✨ Key Features

Exposure to companies driving advancements in the healthcare and medical technology sectors
Focuses on innovative, high-growth potential companies that are shaping the future of medicine
Diversified portfolio across various sub-sectors of the healthcare and medical technology industries
Passively managed to track the performance of the underlying Fidelity Disruptive Medicine Index

⚠️ Primary Risks

Investing in innovative, high-growth companies can be volatile and subject to significant price fluctuations
Concentration risk as the fund is focused on a specific sector and industry
Regulatory and legal risks as the healthcare and medical technology sectors are heavily regulated
Potential for increased competition and disruption within the industry

👤 Best For

The Fidelity Disruptive Medicine ETF may be suitable for investors with a long-term investment horizon who are seeking exposure to innovative companies at the forefront of advancements in the healthcare and medical technology sectors. Investors should have a higher risk tolerance and be comfortable with the volatility associated with investing in emerging and disruptive technologies.